SlideShare a Scribd company logo
SHABNA.G.S
FIRST YEAR MDS
DEPARTMENT OF PUBLIC HEALTH DENTISTRY
GOVERNMENT DENTAL COLLEGE,KOTTAYAM
FUNDAMENTALS OF EPIDEMIOLOGY
1
10/26/2018
10/26/2018
2
CONTENTS
INTRODUCTION
DEFINITIONS
AIMS AND OBJECTIVES OF EPIDEMIOLOGY
ULTIMATE AIM OF EPIDEMIOLOGY
TOOLS OF MEASUREMENT OF EPIDEMIOLOGY
MEASUREMENT OF MORTALITY AND MORBIDITY
EPIDEMIOLOGICAL METHODS
CONCLUSION
BIBLIOGRAPHY
Epidemiology is derived from the word epidemic
[epi=among;demos=population;logos=study]
Epidemiology is the basic science of preventive
and social medicine.
3
10/26/2018
K. Park, Park’s Textbook of preventive and social medicine.18Th edition.
Banarsidas Bhanot Publishers, (2005) 1-2
DEFINITIONS
1.. That branch of medical science which treats
epidemics (Parkin, 1873).
2. The science of the mass phenomena of infectious
diseases (Frost, 1927).
3. The study of disease, any disease, as a mass
phenomenon (Greenwood, 1934).
4. The study of the distribution and determinants of
disease frequency in man (MacMahon, 1960).
4
10/26/2018
Epidemiology has been defined by John M. Last in
1988 as:-
The study of the distribution and determinants of
health-related states or events in specified
populations, and the application of this study to the
control of health problems.
5
10/26/2018
K. Park, Park’s Textbook of preventive and social medicine.18 Th edition.
Banarsidas Bhanot Publishers, (2005) 1-2
AIMS & OBJECTIVES OF
EPIDEMIOLOGY
1. To describe the distribution and magnitude of
health and disease problems in human population.
2. To identify etiological factors (risk factors) in
the pathogenesis of disease.
3. To provide data essential to the planning,
implementation and evaluation of services for
the prevention, control and treatment of disease
and setting priorities among those services.
6
10/26/2018
ULTIMATE AIM OF EPIDEMIOLOGY
1. To eliminate or reduce the health problems of
community.
2. To promote the health and well-being of society
as a whole.
7
10/26/2018
TOOLS OF MEASUREMENT IN EPIDEMIOLOGY
8
10/26/2018
RATE
 Measures the occurrence of an event or disease in
a given population during a given period (one
Year).(Birth rate, growth rate, accident rate)
 Usually expressed per 100 or per 1000 population.
 It has a time dimension, whereas a PROPORTION
does not.
9
10/26/2018
K. Park, Park’s Textbook of preventive and social medicine.18 Th edition.
Banarsidas Bhanot Publishers, (2005) 1-2
RATE
10
10/26/2018
11
10/26/2018
RATIO
 The value obtained by dividing one quantity by
another- X/Y.
 Male to female ratio.
 A ratio often compares two rates, death rates for
women and men at a given age.
12
10/26/2018
 Ratio also expresses relation of size between the
two quantities.
 Numerator is not part of Denominator.
 Expressed as X / Y.
 Male : Female ratio.
 WBC : RBC ratio
13
10/26/2018
14
10/26/2018
15
10/26/2018
PROPORTION
 Usually expressed as a percentage %
 Numerator (which is part of denominator)
 Denominator
 Multiplier
 No time factor
16
10/26/2018
MEASUREMENT OF MORTALITY
• Crude death rate
• Specific death rate
• Proportional mortality rate
• Case fatality rate
• Survival rate
• Adjusted/standardized rates
17
10/26/2018
CRUDE DEATH RATE
18
10/26/2018
19
10/26/2018
20
10/26/2018
21
10/26/2018
22
10/26/2018
23
10/26/2018
24
10/26/2018
25
10/26/2018
26
10/26/2018
27
10/26/2018
28
10/26/2018
29
10/26/2018
30
10/26/2018
31
10/26/2018
32
10/26/2018
33
10/26/2018
34
10/26/2018
35
10/26/2018
36
10/26/2018
37
10/26/2018
MEASUREMENT OF MORBIDITY
38
10/26/2018
39
10/26/2018
RELATION BETWEEN INCIDENCE &
PREVALENCE
10/26/2018
40
RELATION BETWEEN INCIDENCE &
PREVALENCE
10/26/2018
41
Prevalence = Incidence X duration
• Incidence = 10 cases/1000 population/year
• Mean duration of disease = 5 years
• Prevalence = 10 x 5 = 50 per 1000 population
K. Park, Park’s Textbook of preventive and social medicine.18 Th edition.
Banarsidas Bhanot Publishers, (2005) 1-2
SPECIAL INCIDENCES
42
10/26/2018
CUMULATIVE INCIDENCE/ CUMULATIVE
INCIDENCE PROPORTION OR RISK
10/26/2018
43
New cases accumulated in given period of time
in a population at risk
Reflects the probability of individuals in the
population to get the disease in the given time
period (Risk)
Beaglehole R, Bonita R, Kjellström T. Basic Epidemiology. 2nd ed. Geneva:
World Health Organization; 2006.
TYPES OF PREVALENCE
44
10/26/2018
PREVALENCE INCREASED BY
Longer duration of the disease.
 Prolongation of life, with treatment.
 If incidence increases.
 Immigration of new cases.
 Better reporting of cases.
 Emigration of healthy people.
45
10/26/2018
46
10/26/2018
PREVALENCE DECRESED BY
Shorter duration of diseases.
 Improved cure rate.
 Incidence decreases.
 Emigration of new cases.
 Under reporting of cases.
 Immigration of healthy people.
47
10/26/2018
SAMPLING AND ITS TYPES
10/26/2018
48
•A sample is a subset of a population that is used to
represent the entire group as a whole.
•When doing research, it is often impractical to
survey every member of a particular population
because the number of people is simply too large.
10/26/2018
49
10/26/2018
50
WHAT IS A 'GOOD' SAMPLE?
 It represents the population under study in the
characteristics of interest.
 It is adequate in numbers.
WHAT IS AN 'ADEQUATE’ SAMPLE?
 The number must not be too few that we can not rule
out chance.
 It should not be too large that it is uneconomical.
SAMPLING
 Probability (random) sampling
 Sampling in which each sampling unit has a
known and equal probability of being included
in the study.
 Non Probability (Non random) sampling.
WHAT IS A 'RANDOM' SAMPLE?
A 'random' sample, strictly, is a sample
generated from a truly random process.
TYPES OF RANDOM SAMPLING
 Simple random sampling
 Systematic random sampling
 Stratified random sampling
 Cluster sampling
 Multi stage Sampling
10/26/2018
56
SIMPLE RANDOM SAMPLING
10/26/2018
57
• Applicable when population is small, homogeneous
& readily available.
• All subsets of the frame are given an equal
probability. Each element of the frame thus has an
equal probability of selection. A table of random
number or lottery system is used to determine which
units are to be selected.
SYSTEMATIC SAMPLING
10/26/2018
58
Similar to simple random sample. No table of
random numbers – select directly from sampling
frame.
10/26/2018
59
STRATIFIED SAMPLING
10/26/2018
60
The population is divided into two or more
groups
called strata, according to some criterion, such
as
geographic location, age, or income, and sub
samples are randomly selected from each strata.
CLUSTER SAMPLING
10/26/2018
61
 With cluster sampling, the researcher divides the
population into separate groups, called clusters. Then,
a simple random sample of clusters is selected from
the population. The researcher conducts his analysis
on data from the sampled clusters.
10/26/2018
62
MULTISTAGE SAMPLING
 Employed in large country surveys.
 Sample procedures carried out in several stages
using random sampling techniques.
10/26/2018
63
EPIDEMIOLOGIC RESEARCH METHODS
10/26/2018
64
Beaglehole R, Bonita R, Kjellström T. Basic Epidemiology. 2nd ed.
Geneva: World Health Organization; 2006.
DESCRIPTIVE STUDY DESIG
65
10/26/2018
Descriptive design is limited to a description of
the occurrence of a disease in a population.
i.e. identifying the characteristics with which the
disease seems to be associated.
66
10/26/2018
K. Park, Park’s Textbook of preventive and social medicine.18 Th edition.
Banarsidas Bhanot Publishers, (2005) 1-2
Types
Case reports
Case series
Cross sectional
67
10/26/2018
CASE REPORT
A case report is…
“Biomedical story-telling” (Lawrence, 1991)
A stimulant for more comprehensive and prospective
research
68
10/26/2018
CASE SERIES
Experience of a group of patients with a similar
diagnosis
Cases may be identified from a single or multiple
sources
Generally report on new/unique condition
A realistic design for rare disorders .
69
10/26/2018
70
10/26/2018
Advantages
Hypothesis triggering
Informative for very rare disease with few
established risk factors
Disadvantages
Cannot study cause and effect relationships
Cannot assess disease frequency
71
10/26/2018
CROSS SECTIONAL STUDIES
An “Observational” design that studies exposures
and disease status at a single point in time (a
cross-section of the population)
72
10/26/2018
CROSS-SECTIONAL DESIGN
time
Study only exists at this point in time
Study
population
No Disease
Disease
73
10/26/2018
It measures prevalence, not incidence of disease
Example: community surveys
Not suitable for studying rare or a disease with
short duration of expression
74
10/26/2018
75
PROCEDURES
1.Defining the population to be studied
2.Defining the disease under study
3. Measurement of disease
4. Comparing with known indices
5.Formulation of an aetiological hypothesis
10/26/2018
STEP 1: DEFINING THE
POPULATION
A defined population should not only be in terms of
total number
but also in terms of age, sex, location etc.
76
10/26/2018
The defined population-
i) could be a whole geographic region or;
a representative sample not be different from
other
communities in the region
ii) large enough
iii) stable
77
10/26/2018
78
“SNAPSHOT STUDY”
10/26/2018
STEP 2: DEFINING THE
DISEASE
 define the disease which can be
• measured and
• identified with a degree of accuracy.
 could be different from the clinician’s definition
of a disease
79
10/26/2018
STEP 3:MEASUREMENT OF DISEASE
Data collection
• Clinical examination
• Questionnaires
80
10/26/2018
STEP 4: COMPARING WITH KNOWN
INDICES
Comparisons are made with known indices to
arrive at clues to the disease’s etiology
81
10/26/2018
Cross sectional
Descriptive Analytical
82
Prevalence Analysis to find out whether - any
association with a characteristic
10/26/2018
STEP 5: FORMULATION OF A
HYPOTHESIS
A hypothesis is a supposition, arrived at from
observation or reflection.
46
83
10/26/2018
USES OF DESCRIPTIVE EPIDEMIOLOGY
 data regarding the magnitude of the disease load
and types of disease problems.
 clue to disease etiology and help in the
formulation of an etiological hypothesis.
 background data for planning, organizing and
evaluating preventive service.
K. Park, Park’s Textbook of preventive and social medicine.18 Th edition.
Banarsidas Bhanot Publishers, (2005) 1-2
84
10/26/2018
85
ANALYTICAL
EPIDEMIOLOGY
10/26/2018
ANALYTICALEPIDEMIOLOGY.
Is a type of observational
study
Test the hypothesis.
Investigator measures
but does not intervene
86
10/26/2018
BASIC QUESTION IN ANALYTIC
EPIDEMIOLOGY
 Are exposure and disease linked?
Exposure Disease/
Outcome
87
10/26/2018
 Retrospective study
 Unit of study: Cases/ Control ( Individuals)
 Direction of Inquiry : E  O
 Match controls to cases based on major factors
related to the disease.
CASE-CONTROL DESIGN
88
10/26/2018
CASE-CONTROLDESIGN
Study
population
Dental
erosion
(disease)
No dental
erosion
(no disease)
Alcoholism
present
Alcoholism
absent
Alcoholism
present
Alcoholism
absent
present
past
time
Study begins here
89
10/26/2018
90
10/26/2018
1. Selection of Cases and Controls
Selection Sources of
cases
Hospitals
General
Population
Diagnostic
Eligibility-
(Operational
definition-
ADA)
Sources of
controls
Hospitals
General Population
Relatives
Neighbourhood 91
10/26/2018
II. Matching
 Defined as the process by which we select
controls in such a way that they are similar to
cases with regards to certain pertinent selected
variables (e g. age, sex, occupation, social status
etc. ) which are known to influence the outcome of
the disease.
Cases
Controls
92
10/26/2018
III. Measurement of Exposure
Information
- interviews
- questionnaires
-studying past hospital records,
employment records etc.
93
10/26/2018
IV. Analysis
- Exposure rate
-Estimation of disease risk associated with
exposure(odds ratio)
94
10/26/2018
Exposure rates
 Direct estimation of the exposure rates to a
suspected factor in diseased and non – diseased
groups.
95
10/26/2018
EXPOSURE OF CASES = A /(A+C) =
80/100 = 80 %
EXPOSURE OF CONTROLS = B / (B+D) =
40/100 = 40 %
Cases
(Dental erosion)
Controls (without
Dental erosion)
Alcohol users 80 (a) 40 (b)
Non- Alcohol
users 20 (c) 60 (d)
96
10/26/2018
Odds Ratio (Cross Product Ratio)
The OR represents the odds that an outcome will
occur given a particular exposure, compared to
the odds of the outcome occurring in the absence
of that exposure.
97
10/26/2018
Cases
(Dental
erosion)
Controls
(without
Dental
erosion)
Alcohol
users
80 (a) 40 (b)
Non-
Alcohol
users
20 (c) 60 (d)
ad 80 x 60
Odds ratio = bc 40 x 20
98
10/26/2018
Cases
(Dental erosion)
Controls (without
Dental erosion)
Alcohol users 80 (a) 40 (b)
Non- Alcohol users
20 (c) 60 (d)
ad 80 x 60
Odds ratio = = = 6
bc 40 x 20
99
10/26/2018
10/26/2018
100
Beaglehole R, Bonita R, Kjellström T. Basic Epidemiology. 2nd ed. Geneva:
World Health Organization; 2006.
10/26/2018
101
CASE-CONTROL STUDY
Strengths
Less expensive and time consuming efficient for
studying rare diseases.
Limitations
Exposure measurements taken after disease
occurrence
103
10/26/2018
Cohort Study
 Longitudinal study, Incidence study,
Forward-looking study.
• Best observational design
• Looking for a difference in the risk
(incidence) of a disease over time
104
10/26/2018
10/26/2018
105
COHORT STUDIES
Cohort study is a type of analytical study which is
undertaken to obtain additional evidence to refute or
support existence of association between suspected
cause and diseases.
Other names of cohort study are Longitudinal study,
Incidence study and forward looking study.
10/26/2018
106
Features of cohort studies
• Cohorts are identified prior to appearance of
disease under investigation.
• The study groups are observed over a period of
time to determine the frequency of disease among
them.
• The study proceeds from cause to effects.
10/26/2018
107
Indications for cohort study
• There is good evidence of an association between
exposure and disease, from other studies.
• Exposure is rare.
• Sufficient fund is available.
10/26/2018
108
Consideration during selection of Cohort
• The cohort must be free from disease under study.
• Both the groups must be comparable in respect of
all variable which influence the occurrence of
disease.
• Diagnostic and eligibility criteria of the disease
must
be defined beforehand.
10/26/2018
109
Types of cohort study
• Prospective study
• Retrospective cohort study
• Ambi-directional cohort study
PROSPECTIVE COHORT STUDY
10/26/2018
110
In the prospective cohorts study, by the time your
study starts exposure and disease has not yet
occurred.
10/26/2018
111
Retrospective Cohort Study
• A retrospective cohort study is one in which the
outcome have all occurred before the start of
investigation.
• Investigator goes back to the past to select study
group from existing records of the past
employment, medical and other records and traces
them forward through time from the past date fixed
on the records usually to the present.
• Known with the name of Historical Cohort and
noncurrent cohort
10/26/2018
112
THE ROLE OF ANILINE DYES AND
DEVELOPMENT OF URINARY BLADDER
CANCER. The investigator recruited about 4622
workers who were working in dyes industry
between 1920 and 1951. So, this recruitment was
based on available records in those factories.
Investigator also revived the death records of this
4622 individuals and looked about any mention of
urinary bladder tumors on their death records, and
then they compared death rates in these
population with that of expected number of deaths
of bladder cancer using national statistics. So, by
the time the studies started, both exposure and
outcome had occurred.
AMBISPECTIVE STUDY
10/26/2018
113
A combination of these two approaches, which is
called as Bidirectional study or Ambispective study,
wherein when your study starts, the exposure has
already occurred and then you follow this exposed
and then exposed individuals, till they develop the
outcome.
10/26/2018
114
 Relative Risk

115
10/26/2018
10/26/2018
116
(a/a+b)
Relative risk= = 2.7
(c/c+d)
Cases
(Dental erosion)
Controls (without
Dental erosion)
Alcohol users 80 (a) 40 (b)
Non- Alcohol
users 20 (c) 60 (d)
117
10/26/2018
10/26/2018
118
COHORT STUDY
Strengths
 Exposure status determined before disease
detection
 Subjects selected before disease detection
 Can study several outcomes for each exposure
Limitations
 Expensive and time-consuming
 Inefficient for rare diseases or diseases with
long latency
 Loss to follow-up
119
10/26/2018
EXPERIMENTAL STUDY
120
10/26/2018
•Experimental or intervention studies are similar
in approach to cohort studies excepting that the
conditions in which study is carried out are
under the direct control of the investigator
EXPERIMENTAL STUDIES:
121
10/26/2018
Thus experimental studies involve some action,
intervention or manipulation such as deliberate
application or withdrawal of the suspected cause or
changing one variable in the causative chain in the
experimental group while making no change in the
control group, and observing and comparing the
outcome of the experiment in both the groups.
122
10/26/2018
AIMS
1. To provide “scientific proof” of aetiological or risk
factors which may permit the modification or
control of those diseases.
2. To provide a method of measuring the
effectiveness and efficiency of health services for
the prevention, control and treatment of diseases
and improve the health of the community.
123
10/26/2018
THE EXPERIMENTAL DESIGN
124
Reference/target population
Experimental/study population
Participant population Non-participant population
Intervention
group
Control
group
outcome outcome
compare
10/26/2018
RANDOMIZED CONTROLLED TRIALS
• IT IS REALLY AN EPIDEMIOLOGIC
EXPERIMENT.
125
10/26/2018
 Definition: (Stedman’s medical dictionary)
 RCTs are quantitative, comparative, controlled
experiments in which investigators study two or
more interventions in a series of individuals who
receive them in random order.
 The RCT is one of the simplest and most powerful
tools in clinical research.
126
10/26/2018
127
BASIC STEPS IN CONDUCTING A RCT INCLUDE:
1. Drawing up a protocol
2. Selecting reference and experimental population
3. Randomization
4. Manipulation or Intervention
5. Follow-up
6. Assessment of outcome
10/26/2018
1. DRAWING UP A PROTOCOL
 Strict protocol
 Aims & objectives
 Questions to be answered
 Criteria of selection: Study & control groups
 Intervention to be applied
 Standardization of working procedures
 Schedules
 Strictly followed through the study
128
10/26/2018
Preliminary test runs:
• Sometimes, before a protocol is completed,
preliminary(pilot) studies have to be made to find
out the feasibility or operational efficiency of
certain procedures or unknown effects or the
acceptabililty of certain policies.
• Sometimes it is useful to have a short test run of
the protocol to see whether it contains flaws.
• It is important that the final version of the protocol
should be agreed upon by all concerned before
the trial begins.
129
10/26/2018
2. SELECTING REFERENCE AND EXPERIMENTAL POPULATION:
a) Reference or target population:
 It is the population to which the findings of the
trial if found successful, are expected to be
applicable.
 It may be as broad as mankind or it may be
geographically limited or limited to persons in
specific age, gender, occupational or social
groups.
 Eg: population of the whole city, school children,
industrial workers etc
130
10/26/2018
Experimental /Study Population:
 It is derived from the reference population.
 randomly chosen from the reference population.
 same characteristics as reference population.
 choose a stable population whose co-operation is
assured to avoid losses to follow-up.
131
10/26/2018
The participants should fulfill the following criteria:
1. They must give informed consent.
2. Should be representative of the population.
3. Should be qualified or eligible for the trial.
Eg: new drug : treatment of anaemia.
132
10/26/2018
3. RANDOMIZATION
 “Heart" of a control trial.
 It is the statistical procedure by which the
participants are randomly allocated into groups
usually called the "study" and "control" groups.
 It is an attempt to eliminate "bias" and allow for
comparability.
133
10/26/2018
• Randomization eliminates “selection bias”
• Randomization is done only after the participant
has entered the study and it can be done by
using table of random numbers.
• In otherwords, by random allocation, every
individual gets an equal chance of being allocated
into either group or any of the trial groups.
134
10/26/2018
135
10/26/2018
 The essential difference between a randomized
controlled trial and an analytical study is that the
latter, there is no randomization because a
differentiation into disease and non-disease
(exposed and non-exposed) groups has already
taken place.
 The only option left to ensure comparability in
analytical studies is by matching.
136
10/26/2018
4. MANIPULATION
• This refers to the deliberate application or
withdrawal of the suspected causal factor as laid
down in the protocol.
• Eg : drug, vaccine, dietary component, habit
137
10/26/2018
Manipulation creates
• An independent variable (drug, vaccine, new
procedure) whose effect is then determined by
the measurement of the final outcome, which
constitutes the dependant variable.(incidence of
disease, survival time, recovery period)
138
10/26/2018
 5. FOLLOW-UP
 Examination of groups at defined intervals of time
under the same conditions, in a standard manner,
with equal intensity, same circumstances, same
time frame.
 Follow-up can vary from a short period to many
years.
 Over the years, there may be loss of subjects
from either group due to a number of reasons.
This is called as “attrition”.
 Death
 Migration
 Loss of interest
139
10/26/2018
6. ASSESSMENT
The final step of the outcome of he trial in terms of:
a) Positive results: that is, benefits of the
experimental measure such as reduced
incidence or severity of the disease, cost to the
health service or other appropriate outcome in
the study and control groups.
b) Negative results: that is, adverse effects, severity
and frequency of side effects and complications,
if any including death.
140
10/26/2018
 Errors in assessment can lead to “Bias”.
 Bias can arise from three sources:
1. Subject variation
2. Observer bias
3. Evaluation Bias
 Randomization cannot guard against
these sort of bias.
To avoid the above situations, “Blinding”
is done.
141
10/26/2018
WHAT IS BIAS??
Bias is any systematic error in the determination of
the association between the exposure and disease.
142
10/26/2018
TYPES OF BIAS:
1. Non-representative sample drawn from study
population:
- Random sampling
2. Biased allocation of subjects done to the
intervention and control group:
- Ensure ‘random allocation’
3. Observers bias:
- Ensure double blinding
4. Respondents bias:
- Ensure atleast single blinding or placebo for
controls.
143
10/26/2018
5. Contamination bias:
( due to co-intervention with some other
intervention in addition to the intervention under
study, by the subjects)
- Explain in detail the requirement of your
research to the subjects and win over their
cooperation; keep evaluating for any possible co-
intervention by subjects.
144
10/26/2018
6. Bias due to dropouts and loss of follow up:
- Ensure periodic follow up
- develop methods to retrieve the lost subjects.
- Compare the characteristics of those who
remain in study with those have been lost to
follow-up and see if there are significant
differences between them.
145
10/26/2018
10. Confounding bias:
- Ensure random allocation to the groups.
- do a baseline comparision.
- record the data on confounders for
subsequent
treatment during analysis.
146
10/26/2018
BLINDING
 In experiments, more specifically in clinical trials it
is a researcher knows which treatment is given to
which subjects, there is likelihood of bias
creeping in while assessment of response by
investigator.
 Bias can also creep in while describing response
to investigator in case participating subjects know
the treatment given.
147
10/26/2018
 Single blind: Participant
 Double blind : Participant + Investigator
 Triple blind : Participant + Investigator + Analyzer
Blinding is not so important when the final
outcome will be death of the patient.
148
10/26/2018
Methods for achieving double blinding
MATCHING
If two treatments are available in the form of tablets
then matching both tablets in terms of color, shape,
strength, texture etc.
149
10/26/2018
STUDY DESIGNS OF CONTROLLED TRIALS
1. CONCURRENT PARALLEL STUDY DESIGN
2. CROSS-OVER TYPE OF STUDY DESIGNS
150
10/26/2018
151
10/26/2018
TYPES OF RANDOMIZED CONTROLLED TRIALS
1. Clinical trials
2. Community intervention trials
3. Preventive trials
4. Risk factor trials
5. Cessation experiment
6. Trial of aetiological agents
7. Evaluation of health services
152
10/26/2018
CONCLUSION
EPIDEMIOLOGY IN PUBLIC HEALTH
1. Preventing disease and promoting health.
2. Community health assessment (Community
Diagnosis) and priority setting.
3.Improving diagnosis, treatment and prognosis
of clinical diseases.
4.Evaluating health interventions and programmes
10/26/2018
153
BIBLIOGRAPHY
1.Park's Textbook of Preventive and Social
Medicine-24TH EDITION.
2.Jekel's Epidemiology, Biostatistics, Preventive
Medicine, and Public Health, 4th Edition.
10/26/2018
154
3.Epidemiology. Leon Gordis 3rd Edition.
4.Basic epidemiology. R.Bonita, R.Beaglehole,
T. Kjellstrom 2nd Edition
1
155
10/26/2018

More Related Content

PPTX
malignant epithelial non odontogenic neoplasm
PDF
Matrices, retainers and wedges
PPTX
Advances in CBCT in cleft patients
PPTX
Amelogenesis imperfecta, hypoplastic type - Dr Sanjana Ravindra
PPTX
dental amalgam material aspects
PDF
radiographic-caries-diagnosis
PPTX
Radiographic interpretation
PDF
Endodontic diagnosis and treatment planning slides
malignant epithelial non odontogenic neoplasm
Matrices, retainers and wedges
Advances in CBCT in cleft patients
Amelogenesis imperfecta, hypoplastic type - Dr Sanjana Ravindra
dental amalgam material aspects
radiographic-caries-diagnosis
Radiographic interpretation
Endodontic diagnosis and treatment planning slides

What's hot (20)

PPTX
Apexification & apexogenesis
PDF
Etchant in dentistry
PPTX
Extraction instruments | Dental surgery | by Dr.mohammad nameer
PPTX
1.microdontia
PPTX
Nolla staging and Dental Age(Orthdontics)
PDF
Apexification Procedure - Pediatric Dental Lecture
PPT
26. designing of rpd
PDF
Apexogenesis Procedure - A Pediatric Lecture
PPT
Anemia/dental courses
PPTX
dental composite
PPTX
pedodontics.....non pharmacological methods of behaviour management
PPTX
Suturing techniques involved in dental surgery
PPTX
Oral manifestations of nutritional deficiencies
POT
PPTX
Management of impacted mandibular third molar /certified fixed orthodontic ...
PPTX
Obturation Techniques in Primary Teeth
PPTX
Dens evaginatus
PPTX
Smile Design
PPTX
Metastatic tumors of jaws
PDF
Adam's clasp
Apexification & apexogenesis
Etchant in dentistry
Extraction instruments | Dental surgery | by Dr.mohammad nameer
1.microdontia
Nolla staging and Dental Age(Orthdontics)
Apexification Procedure - Pediatric Dental Lecture
26. designing of rpd
Apexogenesis Procedure - A Pediatric Lecture
Anemia/dental courses
dental composite
pedodontics.....non pharmacological methods of behaviour management
Suturing techniques involved in dental surgery
Oral manifestations of nutritional deficiencies
Management of impacted mandibular third molar /certified fixed orthodontic ...
Obturation Techniques in Primary Teeth
Dens evaginatus
Smile Design
Metastatic tumors of jaws
Adam's clasp
Ad

Similar to Epidemiology fundamentals (20)

PPT
4.Epidemiology-–-Definition-Aims-introduction-measurements-study-designs-1.ppt
PPTX
Fundamentals and Study Design of Epidemiology
PPTX
epidemiology (Descriptive and analytical).pptx
PPTX
Epidemiology lecture of Community Medicine
PPTX
Epidemiological Mehods [Autosaved].pptx
PPTX
epidemiology (aim, component, principles).pptx
PPTX
PRINCIPLE OF EPIDEMIOLOGY.pptx
PPTX
Modern epidemiology
 
PPTX
Epidemiology.pptx
PPT
General Epidemiology.ppt.#############..
PPT
Epidemiology class swati
PPTX
Validation of Two Prognostic Mortality Indices at a Program for All-Inclusive...
PPTX
MAIN 2._biostatistics.pptx biostatistics
PPTX
5.principles and methods of epidemiology
PPTX
EPIDEMIOLOGICAL METHODS -MOLECULAR, SEROLOGICAL
PDF
What is epidemiology?.pdf
PPTX
Epidemiology Introduction
PPTX
Lec 2 Disease Burden & Epidemiology.pptx
PPTX
Epidemiology
PPTX
RANDOMIZED CONTROL TRIALS PowerPoint presentation
4.Epidemiology-–-Definition-Aims-introduction-measurements-study-designs-1.ppt
Fundamentals and Study Design of Epidemiology
epidemiology (Descriptive and analytical).pptx
Epidemiology lecture of Community Medicine
Epidemiological Mehods [Autosaved].pptx
epidemiology (aim, component, principles).pptx
PRINCIPLE OF EPIDEMIOLOGY.pptx
Modern epidemiology
 
Epidemiology.pptx
General Epidemiology.ppt.#############..
Epidemiology class swati
Validation of Two Prognostic Mortality Indices at a Program for All-Inclusive...
MAIN 2._biostatistics.pptx biostatistics
5.principles and methods of epidemiology
EPIDEMIOLOGICAL METHODS -MOLECULAR, SEROLOGICAL
What is epidemiology?.pdf
Epidemiology Introduction
Lec 2 Disease Burden & Epidemiology.pptx
Epidemiology
RANDOMIZED CONTROL TRIALS PowerPoint presentation
Ad

Recently uploaded (20)

PPTX
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PDF
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
PPTX
Fundamentals of human energy transfer .pptx
PDF
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
PPTX
surgery guide for USMLE step 2-part 1.pptx
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
PPTX
Acid Base Disorders educational power point.pptx
PPTX
History and examination of abdomen, & pelvis .pptx
PPT
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
PPT
OPIOID ANALGESICS AND THEIR IMPLICATIONS
PPTX
Respiratory drugs, drugs acting on the respi system
PPTX
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
PDF
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
PPTX
Note on Abortion.pptx for the student note
PPTX
neonatal infection(7392992y282939y5.pptx
PDF
CT Anatomy for Radiotherapy.pdf eryuioooop
PPTX
Slider: TOC sampling methods for cleaning validation
PPTX
Imaging of parasitic D. Case Discussions.pptx
NEET PG 2025 Pharmacology Recall | Real Exam Questions from 3rd August with D...
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
Intl J Gynecology Obste - 2021 - Melamed - FIGO International Federation o...
Fundamentals of human energy transfer .pptx
Deadly Stampede at Yaounde’s Olembe Stadium Forensic.pdf
surgery guide for USMLE step 2-part 1.pptx
MENTAL HEALTH - NOTES.ppt for nursing students
Pathophysiology And Clinical Features Of Peripheral Nervous System .pptx
Acid Base Disorders educational power point.pptx
History and examination of abdomen, & pelvis .pptx
1b - INTRODUCTION TO EPIDEMIOLOGY (comm med).ppt
OPIOID ANALGESICS AND THEIR IMPLICATIONS
Respiratory drugs, drugs acting on the respi system
ca esophagus molecula biology detailaed molecular biology of tumors of esophagus
NEET PG 2025 | 200 High-Yield Recall Topics Across All Subjects
Note on Abortion.pptx for the student note
neonatal infection(7392992y282939y5.pptx
CT Anatomy for Radiotherapy.pdf eryuioooop
Slider: TOC sampling methods for cleaning validation
Imaging of parasitic D. Case Discussions.pptx

Epidemiology fundamentals

  • 1. SHABNA.G.S FIRST YEAR MDS DEPARTMENT OF PUBLIC HEALTH DENTISTRY GOVERNMENT DENTAL COLLEGE,KOTTAYAM FUNDAMENTALS OF EPIDEMIOLOGY 1 10/26/2018
  • 2. 10/26/2018 2 CONTENTS INTRODUCTION DEFINITIONS AIMS AND OBJECTIVES OF EPIDEMIOLOGY ULTIMATE AIM OF EPIDEMIOLOGY TOOLS OF MEASUREMENT OF EPIDEMIOLOGY MEASUREMENT OF MORTALITY AND MORBIDITY EPIDEMIOLOGICAL METHODS CONCLUSION BIBLIOGRAPHY
  • 3. Epidemiology is derived from the word epidemic [epi=among;demos=population;logos=study] Epidemiology is the basic science of preventive and social medicine. 3 10/26/2018 K. Park, Park’s Textbook of preventive and social medicine.18Th edition. Banarsidas Bhanot Publishers, (2005) 1-2
  • 4. DEFINITIONS 1.. That branch of medical science which treats epidemics (Parkin, 1873). 2. The science of the mass phenomena of infectious diseases (Frost, 1927). 3. The study of disease, any disease, as a mass phenomenon (Greenwood, 1934). 4. The study of the distribution and determinants of disease frequency in man (MacMahon, 1960). 4 10/26/2018
  • 5. Epidemiology has been defined by John M. Last in 1988 as:- The study of the distribution and determinants of health-related states or events in specified populations, and the application of this study to the control of health problems. 5 10/26/2018 K. Park, Park’s Textbook of preventive and social medicine.18 Th edition. Banarsidas Bhanot Publishers, (2005) 1-2
  • 6. AIMS & OBJECTIVES OF EPIDEMIOLOGY 1. To describe the distribution and magnitude of health and disease problems in human population. 2. To identify etiological factors (risk factors) in the pathogenesis of disease. 3. To provide data essential to the planning, implementation and evaluation of services for the prevention, control and treatment of disease and setting priorities among those services. 6 10/26/2018
  • 7. ULTIMATE AIM OF EPIDEMIOLOGY 1. To eliminate or reduce the health problems of community. 2. To promote the health and well-being of society as a whole. 7 10/26/2018
  • 8. TOOLS OF MEASUREMENT IN EPIDEMIOLOGY 8 10/26/2018
  • 9. RATE  Measures the occurrence of an event or disease in a given population during a given period (one Year).(Birth rate, growth rate, accident rate)  Usually expressed per 100 or per 1000 population.  It has a time dimension, whereas a PROPORTION does not. 9 10/26/2018 K. Park, Park’s Textbook of preventive and social medicine.18 Th edition. Banarsidas Bhanot Publishers, (2005) 1-2
  • 12. RATIO  The value obtained by dividing one quantity by another- X/Y.  Male to female ratio.  A ratio often compares two rates, death rates for women and men at a given age. 12 10/26/2018
  • 13.  Ratio also expresses relation of size between the two quantities.  Numerator is not part of Denominator.  Expressed as X / Y.  Male : Female ratio.  WBC : RBC ratio 13 10/26/2018
  • 16. PROPORTION  Usually expressed as a percentage %  Numerator (which is part of denominator)  Denominator  Multiplier  No time factor 16 10/26/2018
  • 17. MEASUREMENT OF MORTALITY • Crude death rate • Specific death rate • Proportional mortality rate • Case fatality rate • Survival rate • Adjusted/standardized rates 17 10/26/2018
  • 40. RELATION BETWEEN INCIDENCE & PREVALENCE 10/26/2018 40
  • 41. RELATION BETWEEN INCIDENCE & PREVALENCE 10/26/2018 41 Prevalence = Incidence X duration • Incidence = 10 cases/1000 population/year • Mean duration of disease = 5 years • Prevalence = 10 x 5 = 50 per 1000 population K. Park, Park’s Textbook of preventive and social medicine.18 Th edition. Banarsidas Bhanot Publishers, (2005) 1-2
  • 43. CUMULATIVE INCIDENCE/ CUMULATIVE INCIDENCE PROPORTION OR RISK 10/26/2018 43 New cases accumulated in given period of time in a population at risk Reflects the probability of individuals in the population to get the disease in the given time period (Risk) Beaglehole R, Bonita R, Kjellström T. Basic Epidemiology. 2nd ed. Geneva: World Health Organization; 2006.
  • 45. PREVALENCE INCREASED BY Longer duration of the disease.  Prolongation of life, with treatment.  If incidence increases.  Immigration of new cases.  Better reporting of cases.  Emigration of healthy people. 45 10/26/2018
  • 47. PREVALENCE DECRESED BY Shorter duration of diseases.  Improved cure rate.  Incidence decreases.  Emigration of new cases.  Under reporting of cases.  Immigration of healthy people. 47 10/26/2018
  • 48. SAMPLING AND ITS TYPES 10/26/2018 48 •A sample is a subset of a population that is used to represent the entire group as a whole. •When doing research, it is often impractical to survey every member of a particular population because the number of people is simply too large.
  • 51. WHAT IS A 'GOOD' SAMPLE?  It represents the population under study in the characteristics of interest.  It is adequate in numbers.
  • 52. WHAT IS AN 'ADEQUATE’ SAMPLE?  The number must not be too few that we can not rule out chance.  It should not be too large that it is uneconomical.
  • 53. SAMPLING  Probability (random) sampling  Sampling in which each sampling unit has a known and equal probability of being included in the study.  Non Probability (Non random) sampling.
  • 54. WHAT IS A 'RANDOM' SAMPLE? A 'random' sample, strictly, is a sample generated from a truly random process.
  • 55. TYPES OF RANDOM SAMPLING  Simple random sampling  Systematic random sampling  Stratified random sampling  Cluster sampling  Multi stage Sampling
  • 57. SIMPLE RANDOM SAMPLING 10/26/2018 57 • Applicable when population is small, homogeneous & readily available. • All subsets of the frame are given an equal probability. Each element of the frame thus has an equal probability of selection. A table of random number or lottery system is used to determine which units are to be selected.
  • 58. SYSTEMATIC SAMPLING 10/26/2018 58 Similar to simple random sample. No table of random numbers – select directly from sampling frame.
  • 60. STRATIFIED SAMPLING 10/26/2018 60 The population is divided into two or more groups called strata, according to some criterion, such as geographic location, age, or income, and sub samples are randomly selected from each strata.
  • 61. CLUSTER SAMPLING 10/26/2018 61  With cluster sampling, the researcher divides the population into separate groups, called clusters. Then, a simple random sample of clusters is selected from the population. The researcher conducts his analysis on data from the sampled clusters.
  • 63. MULTISTAGE SAMPLING  Employed in large country surveys.  Sample procedures carried out in several stages using random sampling techniques. 10/26/2018 63
  • 64. EPIDEMIOLOGIC RESEARCH METHODS 10/26/2018 64 Beaglehole R, Bonita R, Kjellström T. Basic Epidemiology. 2nd ed. Geneva: World Health Organization; 2006.
  • 66. Descriptive design is limited to a description of the occurrence of a disease in a population. i.e. identifying the characteristics with which the disease seems to be associated. 66 10/26/2018 K. Park, Park’s Textbook of preventive and social medicine.18 Th edition. Banarsidas Bhanot Publishers, (2005) 1-2
  • 68. CASE REPORT A case report is… “Biomedical story-telling” (Lawrence, 1991) A stimulant for more comprehensive and prospective research 68 10/26/2018
  • 69. CASE SERIES Experience of a group of patients with a similar diagnosis Cases may be identified from a single or multiple sources Generally report on new/unique condition A realistic design for rare disorders . 69 10/26/2018
  • 71. Advantages Hypothesis triggering Informative for very rare disease with few established risk factors Disadvantages Cannot study cause and effect relationships Cannot assess disease frequency 71 10/26/2018
  • 72. CROSS SECTIONAL STUDIES An “Observational” design that studies exposures and disease status at a single point in time (a cross-section of the population) 72 10/26/2018
  • 73. CROSS-SECTIONAL DESIGN time Study only exists at this point in time Study population No Disease Disease 73 10/26/2018
  • 74. It measures prevalence, not incidence of disease Example: community surveys Not suitable for studying rare or a disease with short duration of expression 74 10/26/2018
  • 75. 75 PROCEDURES 1.Defining the population to be studied 2.Defining the disease under study 3. Measurement of disease 4. Comparing with known indices 5.Formulation of an aetiological hypothesis 10/26/2018
  • 76. STEP 1: DEFINING THE POPULATION A defined population should not only be in terms of total number but also in terms of age, sex, location etc. 76 10/26/2018
  • 77. The defined population- i) could be a whole geographic region or; a representative sample not be different from other communities in the region ii) large enough iii) stable 77 10/26/2018
  • 79. STEP 2: DEFINING THE DISEASE  define the disease which can be • measured and • identified with a degree of accuracy.  could be different from the clinician’s definition of a disease 79 10/26/2018
  • 80. STEP 3:MEASUREMENT OF DISEASE Data collection • Clinical examination • Questionnaires 80 10/26/2018
  • 81. STEP 4: COMPARING WITH KNOWN INDICES Comparisons are made with known indices to arrive at clues to the disease’s etiology 81 10/26/2018
  • 82. Cross sectional Descriptive Analytical 82 Prevalence Analysis to find out whether - any association with a characteristic 10/26/2018
  • 83. STEP 5: FORMULATION OF A HYPOTHESIS A hypothesis is a supposition, arrived at from observation or reflection. 46 83 10/26/2018
  • 84. USES OF DESCRIPTIVE EPIDEMIOLOGY  data regarding the magnitude of the disease load and types of disease problems.  clue to disease etiology and help in the formulation of an etiological hypothesis.  background data for planning, organizing and evaluating preventive service. K. Park, Park’s Textbook of preventive and social medicine.18 Th edition. Banarsidas Bhanot Publishers, (2005) 1-2 84 10/26/2018
  • 86. ANALYTICALEPIDEMIOLOGY. Is a type of observational study Test the hypothesis. Investigator measures but does not intervene 86 10/26/2018
  • 87. BASIC QUESTION IN ANALYTIC EPIDEMIOLOGY  Are exposure and disease linked? Exposure Disease/ Outcome 87 10/26/2018
  • 88.  Retrospective study  Unit of study: Cases/ Control ( Individuals)  Direction of Inquiry : E  O  Match controls to cases based on major factors related to the disease. CASE-CONTROL DESIGN 88 10/26/2018
  • 91. 1. Selection of Cases and Controls Selection Sources of cases Hospitals General Population Diagnostic Eligibility- (Operational definition- ADA) Sources of controls Hospitals General Population Relatives Neighbourhood 91 10/26/2018
  • 92. II. Matching  Defined as the process by which we select controls in such a way that they are similar to cases with regards to certain pertinent selected variables (e g. age, sex, occupation, social status etc. ) which are known to influence the outcome of the disease. Cases Controls 92 10/26/2018
  • 93. III. Measurement of Exposure Information - interviews - questionnaires -studying past hospital records, employment records etc. 93 10/26/2018
  • 94. IV. Analysis - Exposure rate -Estimation of disease risk associated with exposure(odds ratio) 94 10/26/2018
  • 95. Exposure rates  Direct estimation of the exposure rates to a suspected factor in diseased and non – diseased groups. 95 10/26/2018
  • 96. EXPOSURE OF CASES = A /(A+C) = 80/100 = 80 % EXPOSURE OF CONTROLS = B / (B+D) = 40/100 = 40 % Cases (Dental erosion) Controls (without Dental erosion) Alcohol users 80 (a) 40 (b) Non- Alcohol users 20 (c) 60 (d) 96 10/26/2018
  • 97. Odds Ratio (Cross Product Ratio) The OR represents the odds that an outcome will occur given a particular exposure, compared to the odds of the outcome occurring in the absence of that exposure. 97 10/26/2018
  • 98. Cases (Dental erosion) Controls (without Dental erosion) Alcohol users 80 (a) 40 (b) Non- Alcohol users 20 (c) 60 (d) ad 80 x 60 Odds ratio = bc 40 x 20 98 10/26/2018
  • 99. Cases (Dental erosion) Controls (without Dental erosion) Alcohol users 80 (a) 40 (b) Non- Alcohol users 20 (c) 60 (d) ad 80 x 60 Odds ratio = = = 6 bc 40 x 20 99 10/26/2018
  • 100. 10/26/2018 100 Beaglehole R, Bonita R, Kjellström T. Basic Epidemiology. 2nd ed. Geneva: World Health Organization; 2006.
  • 102. CASE-CONTROL STUDY Strengths Less expensive and time consuming efficient for studying rare diseases. Limitations Exposure measurements taken after disease occurrence 103 10/26/2018
  • 103. Cohort Study  Longitudinal study, Incidence study, Forward-looking study. • Best observational design • Looking for a difference in the risk (incidence) of a disease over time 104 10/26/2018
  • 104. 10/26/2018 105 COHORT STUDIES Cohort study is a type of analytical study which is undertaken to obtain additional evidence to refute or support existence of association between suspected cause and diseases. Other names of cohort study are Longitudinal study, Incidence study and forward looking study.
  • 105. 10/26/2018 106 Features of cohort studies • Cohorts are identified prior to appearance of disease under investigation. • The study groups are observed over a period of time to determine the frequency of disease among them. • The study proceeds from cause to effects.
  • 106. 10/26/2018 107 Indications for cohort study • There is good evidence of an association between exposure and disease, from other studies. • Exposure is rare. • Sufficient fund is available.
  • 107. 10/26/2018 108 Consideration during selection of Cohort • The cohort must be free from disease under study. • Both the groups must be comparable in respect of all variable which influence the occurrence of disease. • Diagnostic and eligibility criteria of the disease must be defined beforehand.
  • 108. 10/26/2018 109 Types of cohort study • Prospective study • Retrospective cohort study • Ambi-directional cohort study
  • 109. PROSPECTIVE COHORT STUDY 10/26/2018 110 In the prospective cohorts study, by the time your study starts exposure and disease has not yet occurred.
  • 110. 10/26/2018 111 Retrospective Cohort Study • A retrospective cohort study is one in which the outcome have all occurred before the start of investigation. • Investigator goes back to the past to select study group from existing records of the past employment, medical and other records and traces them forward through time from the past date fixed on the records usually to the present. • Known with the name of Historical Cohort and noncurrent cohort
  • 111. 10/26/2018 112 THE ROLE OF ANILINE DYES AND DEVELOPMENT OF URINARY BLADDER CANCER. The investigator recruited about 4622 workers who were working in dyes industry between 1920 and 1951. So, this recruitment was based on available records in those factories. Investigator also revived the death records of this 4622 individuals and looked about any mention of urinary bladder tumors on their death records, and then they compared death rates in these population with that of expected number of deaths of bladder cancer using national statistics. So, by the time the studies started, both exposure and outcome had occurred.
  • 112. AMBISPECTIVE STUDY 10/26/2018 113 A combination of these two approaches, which is called as Bidirectional study or Ambispective study, wherein when your study starts, the exposure has already occurred and then you follow this exposed and then exposed individuals, till they develop the outcome.
  • 116. (a/a+b) Relative risk= = 2.7 (c/c+d) Cases (Dental erosion) Controls (without Dental erosion) Alcohol users 80 (a) 40 (b) Non- Alcohol users 20 (c) 60 (d) 117 10/26/2018
  • 118. COHORT STUDY Strengths  Exposure status determined before disease detection  Subjects selected before disease detection  Can study several outcomes for each exposure Limitations  Expensive and time-consuming  Inefficient for rare diseases or diseases with long latency  Loss to follow-up 119 10/26/2018
  • 120. •Experimental or intervention studies are similar in approach to cohort studies excepting that the conditions in which study is carried out are under the direct control of the investigator EXPERIMENTAL STUDIES: 121 10/26/2018
  • 121. Thus experimental studies involve some action, intervention or manipulation such as deliberate application or withdrawal of the suspected cause or changing one variable in the causative chain in the experimental group while making no change in the control group, and observing and comparing the outcome of the experiment in both the groups. 122 10/26/2018
  • 122. AIMS 1. To provide “scientific proof” of aetiological or risk factors which may permit the modification or control of those diseases. 2. To provide a method of measuring the effectiveness and efficiency of health services for the prevention, control and treatment of diseases and improve the health of the community. 123 10/26/2018
  • 123. THE EXPERIMENTAL DESIGN 124 Reference/target population Experimental/study population Participant population Non-participant population Intervention group Control group outcome outcome compare 10/26/2018
  • 124. RANDOMIZED CONTROLLED TRIALS • IT IS REALLY AN EPIDEMIOLOGIC EXPERIMENT. 125 10/26/2018
  • 125.  Definition: (Stedman’s medical dictionary)  RCTs are quantitative, comparative, controlled experiments in which investigators study two or more interventions in a series of individuals who receive them in random order.  The RCT is one of the simplest and most powerful tools in clinical research. 126 10/26/2018
  • 126. 127 BASIC STEPS IN CONDUCTING A RCT INCLUDE: 1. Drawing up a protocol 2. Selecting reference and experimental population 3. Randomization 4. Manipulation or Intervention 5. Follow-up 6. Assessment of outcome 10/26/2018
  • 127. 1. DRAWING UP A PROTOCOL  Strict protocol  Aims & objectives  Questions to be answered  Criteria of selection: Study & control groups  Intervention to be applied  Standardization of working procedures  Schedules  Strictly followed through the study 128 10/26/2018
  • 128. Preliminary test runs: • Sometimes, before a protocol is completed, preliminary(pilot) studies have to be made to find out the feasibility or operational efficiency of certain procedures or unknown effects or the acceptabililty of certain policies. • Sometimes it is useful to have a short test run of the protocol to see whether it contains flaws. • It is important that the final version of the protocol should be agreed upon by all concerned before the trial begins. 129 10/26/2018
  • 129. 2. SELECTING REFERENCE AND EXPERIMENTAL POPULATION: a) Reference or target population:  It is the population to which the findings of the trial if found successful, are expected to be applicable.  It may be as broad as mankind or it may be geographically limited or limited to persons in specific age, gender, occupational or social groups.  Eg: population of the whole city, school children, industrial workers etc 130 10/26/2018
  • 130. Experimental /Study Population:  It is derived from the reference population.  randomly chosen from the reference population.  same characteristics as reference population.  choose a stable population whose co-operation is assured to avoid losses to follow-up. 131 10/26/2018
  • 131. The participants should fulfill the following criteria: 1. They must give informed consent. 2. Should be representative of the population. 3. Should be qualified or eligible for the trial. Eg: new drug : treatment of anaemia. 132 10/26/2018
  • 132. 3. RANDOMIZATION  “Heart" of a control trial.  It is the statistical procedure by which the participants are randomly allocated into groups usually called the "study" and "control" groups.  It is an attempt to eliminate "bias" and allow for comparability. 133 10/26/2018
  • 133. • Randomization eliminates “selection bias” • Randomization is done only after the participant has entered the study and it can be done by using table of random numbers. • In otherwords, by random allocation, every individual gets an equal chance of being allocated into either group or any of the trial groups. 134 10/26/2018
  • 135.  The essential difference between a randomized controlled trial and an analytical study is that the latter, there is no randomization because a differentiation into disease and non-disease (exposed and non-exposed) groups has already taken place.  The only option left to ensure comparability in analytical studies is by matching. 136 10/26/2018
  • 136. 4. MANIPULATION • This refers to the deliberate application or withdrawal of the suspected causal factor as laid down in the protocol. • Eg : drug, vaccine, dietary component, habit 137 10/26/2018
  • 137. Manipulation creates • An independent variable (drug, vaccine, new procedure) whose effect is then determined by the measurement of the final outcome, which constitutes the dependant variable.(incidence of disease, survival time, recovery period) 138 10/26/2018
  • 138.  5. FOLLOW-UP  Examination of groups at defined intervals of time under the same conditions, in a standard manner, with equal intensity, same circumstances, same time frame.  Follow-up can vary from a short period to many years.  Over the years, there may be loss of subjects from either group due to a number of reasons. This is called as “attrition”.  Death  Migration  Loss of interest 139 10/26/2018
  • 139. 6. ASSESSMENT The final step of the outcome of he trial in terms of: a) Positive results: that is, benefits of the experimental measure such as reduced incidence or severity of the disease, cost to the health service or other appropriate outcome in the study and control groups. b) Negative results: that is, adverse effects, severity and frequency of side effects and complications, if any including death. 140 10/26/2018
  • 140.  Errors in assessment can lead to “Bias”.  Bias can arise from three sources: 1. Subject variation 2. Observer bias 3. Evaluation Bias  Randomization cannot guard against these sort of bias. To avoid the above situations, “Blinding” is done. 141 10/26/2018
  • 141. WHAT IS BIAS?? Bias is any systematic error in the determination of the association between the exposure and disease. 142 10/26/2018
  • 142. TYPES OF BIAS: 1. Non-representative sample drawn from study population: - Random sampling 2. Biased allocation of subjects done to the intervention and control group: - Ensure ‘random allocation’ 3. Observers bias: - Ensure double blinding 4. Respondents bias: - Ensure atleast single blinding or placebo for controls. 143 10/26/2018
  • 143. 5. Contamination bias: ( due to co-intervention with some other intervention in addition to the intervention under study, by the subjects) - Explain in detail the requirement of your research to the subjects and win over their cooperation; keep evaluating for any possible co- intervention by subjects. 144 10/26/2018
  • 144. 6. Bias due to dropouts and loss of follow up: - Ensure periodic follow up - develop methods to retrieve the lost subjects. - Compare the characteristics of those who remain in study with those have been lost to follow-up and see if there are significant differences between them. 145 10/26/2018
  • 145. 10. Confounding bias: - Ensure random allocation to the groups. - do a baseline comparision. - record the data on confounders for subsequent treatment during analysis. 146 10/26/2018
  • 146. BLINDING  In experiments, more specifically in clinical trials it is a researcher knows which treatment is given to which subjects, there is likelihood of bias creeping in while assessment of response by investigator.  Bias can also creep in while describing response to investigator in case participating subjects know the treatment given. 147 10/26/2018
  • 147.  Single blind: Participant  Double blind : Participant + Investigator  Triple blind : Participant + Investigator + Analyzer Blinding is not so important when the final outcome will be death of the patient. 148 10/26/2018
  • 148. Methods for achieving double blinding MATCHING If two treatments are available in the form of tablets then matching both tablets in terms of color, shape, strength, texture etc. 149 10/26/2018
  • 149. STUDY DESIGNS OF CONTROLLED TRIALS 1. CONCURRENT PARALLEL STUDY DESIGN 2. CROSS-OVER TYPE OF STUDY DESIGNS 150 10/26/2018
  • 151. TYPES OF RANDOMIZED CONTROLLED TRIALS 1. Clinical trials 2. Community intervention trials 3. Preventive trials 4. Risk factor trials 5. Cessation experiment 6. Trial of aetiological agents 7. Evaluation of health services 152 10/26/2018
  • 152. CONCLUSION EPIDEMIOLOGY IN PUBLIC HEALTH 1. Preventing disease and promoting health. 2. Community health assessment (Community Diagnosis) and priority setting. 3.Improving diagnosis, treatment and prognosis of clinical diseases. 4.Evaluating health interventions and programmes 10/26/2018 153
  • 153. BIBLIOGRAPHY 1.Park's Textbook of Preventive and Social Medicine-24TH EDITION. 2.Jekel's Epidemiology, Biostatistics, Preventive Medicine, and Public Health, 4th Edition. 10/26/2018 154 3.Epidemiology. Leon Gordis 3rd Edition. 4.Basic epidemiology. R.Bonita, R.Beaglehole, T. Kjellstrom 2nd Edition